Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Driven by takeover offers for Ashtead Technology and Lifecore Biomedical, while completely divesting Lifecore following an unattractive deal structure.
Full Quick Take
Driven by takeover offers for Ashtead Technology and Lifecore Biomedical, while completely divesting Lifecore following an unattractive deal structure.
Third Avenue Value Fund underperformed in Q2 2026 as markets chased semiconductors and AI while the Fund stayed disciplined in out-of-favor tangible asset plays.
Full Quick Take
Third Avenue Value Fund underperformed in Q2 2026 as markets chased semiconductors and AI while the Fund stayed disciplined in out-of-favor tangible asset plays.
Trailing the S&P 500 due to defensive positioning and zero AI exposure, while continuing to double down on highly asymmetric, misunderstood micro-cap growth opportunities abroad.
Full Quick Take
Trailing the S&P 500 due to defensive positioning and zero AI exposure, while continuing to double down on highly asymmetric, misunderstood micro-cap growth opportunities abroad.
The fund seeks long-term capital appreciation by taking advantage of market dislocation in legacy sectors, focusing on European financial institutions with improved return on equity and disciplined energy and shipping companies with strong cash flow generation.
Full Quick Take
The fund seeks long-term capital appreciation by taking advantage of market dislocation in legacy sectors, focusing on European financial institutions with improved return on equity and disciplined energy and shipping companies with strong cash flow generation.